Foresite Capital Management II as of March 31, 2020
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 6 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| 10x Genomics Inc Cl A (TXG) | 95.9 | $411M | 6.6M | 62.32 | |
| Epizyme | 1.4 | $5.9M | 380k | 15.51 | |
| Insmed (INSM) | 0.9 | $3.8M | 237k | 16.03 | |
| Aerie Pharmaceuticals | 0.8 | $3.4M | 254k | 13.50 | |
| Acceleron Pharma | 0.7 | $3.1M | 35k | 89.87 | |
| Regenxbio Inc equity us cm (RGNX) | 0.4 | $1.5M | 47k | 32.38 |
